Drug Store News - Levaquin adds new indication to treat skin infections - Brief Article
The FDA has approved a new indication for Ortho-McNeil’s Levaquin Tablets/Injection (levofloxacin tablets/injection), to treat complicated skin and skin structure infections at a dose of 750 mg once daily.
Most Popular
5 Regular Mistakes In Public Speaking
Public Speaking: 7 Secrets Of Great Public Speakers
10 Jobs That Pay $30 An Hour
13 Job Interview Mistakes To Avoid
Thinking Through Uncertainty: CFOs Scrutinize Non-Financial Risk
This is the ninth indication for Levaquin, which is already widely used in 500 mg and 250 mg doses to treat respiratory, urinary and other types of skin infections. Complicated skin and skin structure infections include deep wounds–surgical incisions, bites and lacerations that have become infected, major abscesses and infected ulcers. While often resulting from surgery, complicated skin infections are also common in patients with compromised immune response to infection, such as the elderly and individuals with HIV/AIDS.
COPYRIGHT 2000 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
